
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment
Wei Bin Fang, Min Yao, Gage Brummer, et al.
Oncotarget (2016) Vol. 7, Iss. 31, pp. 49349-49367
Open Access | Times Cited: 108
Wei Bin Fang, Min Yao, Gage Brummer, et al.
Oncotarget (2016) Vol. 7, Iss. 31, pp. 49349-49367
Open Access | Times Cited: 108
Showing 1-25 of 108 citing articles:
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta, Jeffrey W. Pollard
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 887-904
Open Access | Times Cited: 1572
Luca Cassetta, Jeffrey W. Pollard
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 887-904
Open Access | Times Cited: 1572
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1058
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1058
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
Jan Korbecki, Klaudyna Kojder, Donata Simińska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8412-8412
Open Access | Times Cited: 323
Jan Korbecki, Klaudyna Kojder, Donata Simińska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8412-8412
Open Access | Times Cited: 323
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Justine Habault, Jean‐Luc Poyet
Molecules (2019) Vol. 24, Iss. 5, pp. 927-927
Open Access | Times Cited: 260
Justine Habault, Jean‐Luc Poyet
Molecules (2019) Vol. 24, Iss. 5, pp. 927-927
Open Access | Times Cited: 260
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target
Valentina Gambardella, Josefa Castillo, Noelia Tarazona, et al.
Cancer Treatment Reviews (2020) Vol. 86, pp. 102015-102015
Open Access | Times Cited: 251
Valentina Gambardella, Josefa Castillo, Noelia Tarazona, et al.
Cancer Treatment Reviews (2020) Vol. 86, pp. 102015-102015
Open Access | Times Cited: 251
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents
Matteo Santoni, Emanuela Romagnoli, Tiziana Saladino, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1869, Iss. 1, pp. 78-84
Closed Access | Times Cited: 199
Matteo Santoni, Emanuela Romagnoli, Tiziana Saladino, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1869, Iss. 1, pp. 78-84
Closed Access | Times Cited: 199
Tumor-Associated Macrophages as Target for Antitumor Therapy
Katarzyna Sawa-Wejksza, Martyna Kandefer‐Szerszeń
Archivum Immunologiae et Therapiae Experimentalis (2017) Vol. 66, Iss. 2, pp. 97-111
Open Access | Times Cited: 184
Katarzyna Sawa-Wejksza, Martyna Kandefer‐Szerszeń
Archivum Immunologiae et Therapiae Experimentalis (2017) Vol. 66, Iss. 2, pp. 97-111
Open Access | Times Cited: 184
Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer
Tamkin Ahmadzada, Glen Reid, David R. McKenzie
Biophysical Reviews (2018) Vol. 10, Iss. 1, pp. 69-86
Open Access | Times Cited: 182
Tamkin Ahmadzada, Glen Reid, David R. McKenzie
Biophysical Reviews (2018) Vol. 10, Iss. 1, pp. 69-86
Open Access | Times Cited: 182
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 166
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 166
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 146
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 146
Targeting Breast Cancer Stem Cells
Lu Zhang, Wen‐Ming Chen, Suling Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 552-570
Open Access | Times Cited: 107
Lu Zhang, Wen‐Ming Chen, Suling Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 552-570
Open Access | Times Cited: 107
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tian‐Jian Yu, Gen‐Hong Di
Chinese Journal of Cancer Research (2017) Vol. 29, Iss. 3, pp. 237-252
Open Access | Times Cited: 146
Tian‐Jian Yu, Gen‐Hong Di
Chinese Journal of Cancer Research (2017) Vol. 29, Iss. 3, pp. 237-252
Open Access | Times Cited: 146
Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression
Sha Sha, Dongya Yuan, Yuejun Liu, et al.
Biology Open (2017)
Open Access | Times Cited: 108
Sha Sha, Dongya Yuan, Yuejun Liu, et al.
Biology Open (2017)
Open Access | Times Cited: 108
Peptide-based materials for cancer immunotherapy
Lu Zhang, Yanyu Huang, Aaron Lindstrom, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7807-7825
Open Access | Times Cited: 100
Lu Zhang, Yanyu Huang, Aaron Lindstrom, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7807-7825
Open Access | Times Cited: 100
Targeting Innate Immunity in Cancer Therapy
Srikrishnan Rameshbabu, Brian Labadie, Anna Argulian, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 138-138
Open Access | Times Cited: 89
Srikrishnan Rameshbabu, Brian Labadie, Anna Argulian, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 138-138
Open Access | Times Cited: 89
Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5647-5647
Open Access | Times Cited: 70
Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5647-5647
Open Access | Times Cited: 70
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives
Umar Mehraj, Hina Qayoom, Manzoor Ahmad Mir
Breast Cancer (2021) Vol. 28, Iss. 3, pp. 539-555
Closed Access | Times Cited: 70
Umar Mehraj, Hina Qayoom, Manzoor Ahmad Mir
Breast Cancer (2021) Vol. 28, Iss. 3, pp. 539-555
Closed Access | Times Cited: 70
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Umar Mehraj, Umar Mushtaq, Manzoor Ahmad Mir, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 769-783
Closed Access | Times Cited: 63
Umar Mehraj, Umar Mushtaq, Manzoor Ahmad Mir, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 769-783
Closed Access | Times Cited: 63
The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 14
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 14
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma
Shabana Habib, Gabriel Osborn, Zena Willsmore, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 895-911
Open Access | Times Cited: 10
Shabana Habib, Gabriel Osborn, Zena Willsmore, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 895-911
Open Access | Times Cited: 10
The role of macrophage phenotype in regulating the response to radiation therapy
Xiaoshan Shi, Stephen L. Shiao
Translational research (2017) Vol. 191, pp. 64-80
Open Access | Times Cited: 80
Xiaoshan Shi, Stephen L. Shiao
Translational research (2017) Vol. 191, pp. 64-80
Open Access | Times Cited: 80
Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
Weilong Chen, Yuanyuan Qin, Suling Liu
Clinical and Translational Medicine (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 74
Weilong Chen, Yuanyuan Qin, Suling Liu
Clinical and Translational Medicine (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 74
Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-α and MMP-9
Seungeun Lee, Eunhye Lee, Eun-Yi Ko, et al.
Cancer Letters (2018) Vol. 437, pp. 25-34
Closed Access | Times Cited: 70
Seungeun Lee, Eunhye Lee, Eun-Yi Ko, et al.
Cancer Letters (2018) Vol. 437, pp. 25-34
Closed Access | Times Cited: 70
AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
Melissa B. Davis, Shweta Tripathi, Raymond W. Hughley, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0196909-e0196909
Open Access | Times Cited: 60
Melissa B. Davis, Shweta Tripathi, Raymond W. Hughley, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0196909-e0196909
Open Access | Times Cited: 60